Search Results 161-170 of 16554 for ������������KA���:ZA31���24������ ���������������������������������
The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...
2001 Jan; 24(1):60-3. ... Pranzatelli MR, Hanin I, Tate E, Kindel G, Bergin A, Brown CM, Habersang P, Habersang R, Mack KJ, Rosenbaum B, Selby KA, Vasconcellos M.
2024 Sep 24; 84 (13):1178-1189 Epub 2024 Sept 01 ... KA, Niederseer D, Citro R, Vecchione C, Bossone E ... 2023 Apr 24; 16 (8):885-895. View PubMed ...
... 24 hours following surgery. Tranexamic acid is a synthetic drug that has been shown to reduce blood drain output and the need for blood transfusions in both ...
Rochester, Minnesota: 24-008357. Sponsor Protocol Number: VX24-KDO-901. About this study. The purpose of this study is to estimate the prevalence of PKD1 ...
... 24 item - Mental Rotation Test by Peters (MRT) (Peters)). Participants will be given a short tutorial to explain the procedure. CVC placement will use the ...
Learn about these common noncancerous growths and what to do if you have symptoms such as heavy menstrual bleeding.
Mayo Clinic researchers are involved in all areas of uterine fibroid research. In addition to studying the latest in diagnosis and treatment, Mayo Clinic ...
Proteinuria (≥1 gram/24 hours) 24 months after immunosuppressive therapy initiated; Serum creatinine < 3mg/dl; Able to provide consent; Anti-PLA2R level at 24 ...
Rochester, Minnesota: 24-003168. Sponsor Protocol Number: 24-003168. About this study. The purpose of this repository is to provide clinical samples to support ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.